子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 101 | Extract solution and herbal mixture for treatment of hepatitis | US498699 | 1995-07-03 | US5648089A | 1997-07-15 | Tarek Shawkat |
| A newly formulated herbal mixture and herbal nasal drops are provided for ethical use and treatment of vital hepatitis diseases. The herbal formulation is in two parts, which may be used separately or together, including (1) an oral herbal formulation including coarse granules of 9 herbs, ground and added together in specific ratios; and (2) nasal drops prepared from the extract of a single herb, namely Ecballium Elaterium A. Rich. | ||||||
| 102 | Method for improving amoxicillin absorption in mammals by administering the amoxicillin to the mammal in combination with Rosa roxburghii, Artemisiae argyi folium and/or Brassica oleracea var. capitata L. | US438503 | 1995-05-10 | US5628998A | 1997-05-13 | Seiichi Araki; Mamoru Suzuki; Masatoshi Fujimoto; Tadashi Ueki |
| A method for improving amoxicillin absorption in mammals such as pigs by administering the amoxicillin to the mammal in combination with one or more of the following plant substances: Rosa roxburghii, Artemisiae argyi folium and Brassica oleracea var. capitata L. The plant substance is administered in its natural state, dried, or as an extract. | ||||||
| 103 | Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organ | US380322 | 1995-01-30 | US5618537A | 1997-04-08 | Samuel N. Okpanyi |
| Plant-based medicament having tonicising action on smooth muscular organs which are atonic or have decreased tone. The medicament contains Iberis amara, preferably Iberis amara totalis (flowers, seeds, leaves, stalk and roots), in particular as a plant extract or its constituents, optionally together with one or more other constituents selected from the group consisting of Menthae piperitae, Matricariae, Carvi fructus, Melissae folium and Liquiritiae radix, as the sole carrier(s) of the activity. Methods of treating patients comprising administering the medicaments. | ||||||
| 104 | Use of Tarchonanthus camphoratus for repelling insects and alleviating edema, congestion and irritation of the skin | US428175 | 1995-07-10 | US5607674A | 1997-03-04 | Guido Rovesti; Gabriele Segalla; Pietro La Fratta; Michele G. Di Schiena |
| Utilization of the Tarchanthus camphoratus and its derivatives in formulations and compositions having insect repellant, anti-irritant, anti-edema, decongestant and soothing properties. | ||||||
| 105 | Acid resistant calcium carbonate composition containing an aluminum salt, uses therefor and processes for its production | US518763 | 1995-08-24 | US5599388A | 1997-02-04 | Kuan-Ting Wu |
| An improved form of calcium carbonate which is acid resistant to enable its use as a filler material in the making of neutral to weakly acid paper, and a process for producing this acid resistant calcium carbonate are provided. This acid resistant calcium carbonate comprises a mixture of at least about 0.5 to about 10 percent of an aluminum salt, based on the dry weight of calcium carbonate, and calcium carbonate. Preferred aluminum salts are aluminum sulfate, aluminum chloride, and polyaluminum chloride. | ||||||
| 106 | Pharmaceutical composition comprising Rosa roxburghii, Artemisiae argyi folium and Brassica oleracea var. capitata L. used to reduce the symptoms of diarrhea | US433312 | 1995-05-03 | US5556625A | 1996-09-17 | Seiichi Araki; Mamoru Suzuki; Masatoshi Fujimoto; Tadashi Ueki |
| A method of reducing the symptoms of diarrhea by administering to an animal a composition containing Rosa roxburghii, Artemisiae argyi folium, and Brassica oleracea var. capitata L. | ||||||
| 107 | Dry and Porous galenic form based on plants, its method of preparation and its applications | US231997 | 1994-04-21 | US5527783A | 1996-06-18 | Guy Derrieu; Bernard Raynier |
| Solid compositions based on plants, capable of being converted to a dry and porous galenic form (lyophilized or equivalent form) which is undivided or powdered. Said dry and porous galenic form comprises a solid composition II consisting ofa solid composition I composed of:(A) one or more of the plants' active principles included in a homogeneous suspension of fresh or dry plants obtained by (a) cleaning and/or drying of the plant or part of the plant, (b) cryocomminution at a temperature below 0.degree. C. until a particle size of less than about 100 .mu.m is obtained, (c) immersion of the particles for a suitable time in at least one appropriate solvent, (d) separation of the liquid phase and the solid phase of the suspension obtained, (e) expression of the solid phase obtained in (d) by cold pressing, and (f) mixing of the liquid phase obtained in (d) and the expressed liquid obtained in (e), and(B) at least one absorption promoter with a sequestering action,said mixture (A+B) being dried by removal of the solvent; and(C) at least one absorption promoter selected from surfactants,said composition II being lyophilized and optionally associated with excipients which are suitable from a pharmaceutical point of view. | ||||||
| 108 | Pharmaceutical compositions for the treatment of skin disorders | US108640 | 1993-08-26 | US5466452A | 1995-11-14 | Brian A. Whittle |
| A process is provided which is suitable for the preparation of herbal compositions for the treatment of skin disorders such as eczema and psoriasis. The process comprises preparing an extract or extracts of herbs which provide an anti-inflammatory agent, an adrenocortical stimulant and a cortisol protecting agent by steam distillation and decoction and then treating the extracts to reduce the polysaccharide and/or sugar content. This is achieved by fermentation or enzymic action or by extraction with a solvent having a polarity in the range E.degree. 0.4 to 0.95 or by precipitation with an inorganic compound and/or colloid or by a combination of two or more of the above. As a final concentration step, the material is further purified by extraction with a solvent having a polarity in the range mentioned above. The reduction of the sugar/polysaccharide content greatly improves the handling characteristics of the extract which can be dried to a free flowing powder. Tablets and capsules for oral administration can be prepared from the extract and it is also suitable for the preparation of topical compositions. | ||||||
| 109 | Pharmaceutically active composition extracted from tanacetum parthenium, process for its extraction, and pharmaceutical composition containing same | US11526 | 1993-01-29 | US5466451A | 1995-11-14 | Norbert Beuscher; Ingo Willigmann |
| Extraction of pharmaceutically active compositions from a mixture of numerous ingredients, in particular from comminuted plants, such as Tanacetum parthenium, succeeds with a high yield and a surprisingly improved stability of the active substances when the extraction is carried out with a gas, preferably CO.sub.2, in the supercritical state. | ||||||
| 110 | Medicinal composition for treatment of inflammation | US065342 | 1993-05-21 | US5455033A | 1995-10-03 | Melvin Silverman; Geneviere DeGree |
| A medicinal composition for topical application and for use in a method of treatment for genital herpes and other inflammations of the genitalia includes as active ingredients tea tree oil, pau d'arco powder (an extract of lapacho), licorice root extract, and echinacea extract with a local anesthetic, preferably pramoxine hydrochloride. The composition may include soothing ingredients such as aloe vera extract and chamomile extract and is preferably formulated in a cream base. | ||||||
| 111 | Method for the extraction of sesquiterpene lactones | US87672 | 1993-07-08 | US5384121A | 1995-01-24 | Alan Rhodes |
| The present invention relates to a method for the extraction of sesquiterpene lactones from the plant Tanacetum parthenium specifically using polar organic solvents and the use of such extracts in pharmaceutical products. It has been found that by utilization of an extraction procedure in accordance with the current invention, a significantly greater amount of the sesquiterpene lactone parthenolide is extracted from Tanacetum parthenium than is the case when using petroleum spirit as the primary extractant, the solvent usually used in previous studies. | ||||||
| 112 | Therapeutic preparation for topical application to the skin | US905311 | 1992-06-29 | US5350774A | 1994-09-27 | Cathy Palou |
| A therapeutic preparation for topical application to the skin for treating skin disorders such as minor burns, abrasions and the like, which contains myrrh oil. | ||||||
| 113 | Method for treating pressure ulcers using calendula | US900117 | 1992-06-18 | US5266330A | 1993-11-30 | Karen A. Cannon |
| A method for treating human pressure ulcer conditions of bedridden patients using an effective amount of the plant extract calendula officinalis L. in a topical pharmaceutical carrier selected from the group consisting of ointments, lotions, pastes, solvents, jellies, sprays and aerosols. The calendula is present by weight from about 1.0 to 25.0%. Preferably, pressure ulcers are treated by soaking sterile dressings in a 2.5% solution of calendula in saline, and then applying such dressings to the affected area. | ||||||
| 114 | Extracts of the Acanthospermum hispidum plant | US659313 | 1991-04-15 | US5256416A | 1993-10-26 | Klaus Eichmann; Manuel Modolell |
| The invention relates to an aqueous extract of the Acanthospermum hispidum plant and its use as a medicament. The extract is effective as an immunomodulator, in the remedy of radiation sickness, in the prophylaxis and therapy of virus diseases and in the prophylaxis and therapy of retroviral diseases in mammals, and has an antitumor effect. | ||||||
| 115 | Pharmaceutical composition and method of treatment utilizing the composition | US780877 | 1991-10-18 | US5229119A | 1993-07-20 | Avelino Gutierrez Rigo |
| An anti-venom composition comprising extracts of active components of the plants Abelmoscus moschatus and Mikania guaco combined at effective ratios; the method of preparing this composition; the pharmaceutical products derived of said extracts of active components; and a method of treating snakebites, scorpion stinging and the like using said composition. | ||||||
| 116 | Compositions for treating hypercholesterolemia | US768093 | 1991-09-30 | US5116610A | 1992-05-26 | Charles D. Broaddus |
| Cholestyramine and polyol polyesters are administered orally to reduce blood cholesterol levels. | ||||||
| 117 | Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation | US320576 | 1989-03-08 | US5108750A | 1992-04-28 | Yaguang Liu |
| The new pharmaceutical compositions and processes are provided for reducing both hyperlipidemia and platelet-aggregation (PHP).The fine-PHP is composed of following ingredients: Scoparone or Aurapten, Curcumin, Ferulic Acid, Yejuhua-flavonoid and additive ingredient--fish oil. The compositions are nontoxic. | ||||||
| 118 | Silanol-based product for care of the superficial lymphatic vessels | US577794 | 1990-09-05 | US5085870A | 1992-02-04 | Marie-Christine Seguin; Jean Gueyne |
| Aqueous composition for care of the superficial lymphatic vessels, containing one or more silanols or silanol derivatives in conjunction with concholytic acid. | ||||||
| 119 | Immunopotentiator | US254772 | 1988-09-21 | US5055297A | 1991-10-08 | Michio Fujimaki; Shojiro Ikematsu; Masao Hada; Hidetaka Fukue; Katsuhiro Fukutake |
| An immunopotentiator for patients with viruses of an acquired immune deficiency syndrome, which contains Sho-saiko-to (Xiao-Chai-Hu-Tang) or Ninzin-to (Ren-Shen-Tang). Sho-saiko-to (Xiao-Chai-Hu-Tang) or Ninzin-to (Ren-Shen-Tang) according to the formulations of Chinese medicine, is used in situ or in the form of a preparation. | ||||||
| 120 | Compositions for the prevention and medical treatment of parodonthopathy | US339003 | 1989-04-17 | US5043153A | 1991-08-27 | Mihaly Videki; Jozsef Varadi; Katalin Mozsgai; Zsuzsanna Kiss nee Varadi; Geza Malasics; Istvan Puskas; Miklos Sipos; Otto Budavari |
| The invention relates to a composition for the prevention and medical treatment of parondonthopathy. The composition contains the aqueous or aqueous with other solvent extract of greater celandine (Chelidonii herba), peppermint leaf(Menthae pip. fol.), marigold (Celendulae flos), thyme (Thymi herba), millfoil (Millefolii herba), optionally chamomile (Chamomillae flos), melilot leaf (Melissae fol.), and clove (Cariophylli flos) or arnica (Arnicae flos). | ||||||
QQ群二维码
意见反馈
意见反馈